The life sciences company will supply Molybdenum, until December 31st 2013, longing a deal that was to expire on July 31st for a further 2 years.
Nordion, which changed it name from MDS Inc in 2010 last week said it hopes that the isotopes supplied by the National Research Universal reactor to generate about $4 million a month in operating income.
It expected that the profitability in the second half of 2011 finishing to be held back by a planned shutdown of the NRU reactor for inspections and higher costs from importing isotopes from Russia.
